The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The Nanomaterials In Personalized Medicine Market From 2026 To 2030?
The nanomaterials in personalized medicine market has seen significant expansion in recent years. The market is projected to increase from $392.97 billion in 2025 to $438.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical growth can be attributed to advancements in genomics and molecular biology, increasing adoption of targeted therapies, expansion of translational medical research, availability of advanced nanofabrication techniques, and growth of academic-industry collaborations.
The market size for nanomaterials in personalized medicine is projected to experience substantial growth in the upcoming years. It is set to expand to $674.28 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.3%. This anticipated expansion during the forecast period is driven by factors such as an escalating demand for personalized healthcare options, increased investment in precision medicine programs, wider application of nanomaterials in diagnostics and imaging, a heightened emphasis on reducing therapy side effects, and continuous innovation in nano-enabled medical technologies. Significant trends expected in the forecast period include the increasing deployment of targeted nanomaterials for individualized treatments, the growing integration of molecular diagnostics with nanotechnology, a rise in the adoption of nanomaterials for precision drug delivery, the expansion of nanotechnology into regenerative medicine, and an enhanced focus on patient-specific treatment outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp
What Are The Main Drivers Accelerating The Growth Of The Nanomaterials In Personalized Medicine Market?
The growing demand for personalized medicine is projected to drive the expansion of the nanomaterials in personalized medicine market moving forward. This medical methodology involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize results and enhance care. The need for personalized medicine is on the rise, driven by advancements in genomic technologies that enable precise identification of genetic variations and the development of tailored treatments for individuals. Nanomaterials in personalized medicine further enhance this approach by facilitating targeted and patient-specific therapies, thereby improving treatment effectiveness and safety. They allow for the precise delivery of drugs, genes, or RNA, which helps in reducing side effects and optimizing therapeutic outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Thus, the increasing demand for personalized medicine is fundamentally propelling the growth of the nanomaterials in personalized medicine market.
How Are Different Segment Groups Identified Within The Nanomaterials In Personalized Medicine Market?
The nanomaterials in personalized medicine market covered in this report is segmented –
1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles
2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines
5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions
Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels
4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles
Which Trends Are Affecting The Nanomaterials In Personalized Medicine Market Framework?
Leading entities within the nanomaterials in personalized medicine market are increasingly focusing on forming strategic partnerships to expedite clinical development, broaden therapeutic applications, and reduce time-to-market, all while adhering to evolving regulatory frameworks. These strategic collaborations represent alliances where organizations merge their specialized knowledge and assets to hasten innovation and broaden prospects within personalized medicine. As an illustration, in May 2025, Acuitas Therapeutics Inc., a Canadian biotechnology firm, partnered with Integrated DNA Technologies Inc., a genomics solutions provider from the US, to introduce a personalized CRISPR gene-editing therapy administered via their lipid nanoparticles platform. This treatment was successfully applied to a single infant suffering from a rare genetic condition, utilizing precisely aimed CRISPR elements, customized dosage adjustment, and swift bespoke preparation. Such advancements accelerate the delivery of unique, highly tailored treatments. While enhancing therapeutic accuracy and improving patient results, this approach also introduces difficulties related to scalable manufacturing, strict regulatory customization, and very low-volume production.
Which Industry Players Are Present In The Nanomaterials In Personalized Medicine Market?
Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.
Access The Complete Nanomaterials In Personalized Medicine Market Report:
Which Region Leads The Nanomaterials In Personalized Medicine Market By Size?
North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Nanomaterials In Personalized Medicine Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp
Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company
Nanomaterials In Cosmetic And Personal Care Market Report 2026
Nanomedicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report
Healthcare Nanotechnology Market Report 2026
https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model